Subsequent Events (Details) - Subsequent Event - BioTrace $ in Millions |
Oct. 03, 2022
USD ($)
item
|
|---|---|
| Subsequent Events | |
| Cash paid at closing | $ | $ 2.5 |
| Achievement of First Device Sold in the United States | United States | |
| Subsequent Events | |
| Number of annual payments | item | 6 |
| Net sales revenue (as a percent) | 10.00% |
| X | ||||||||||
- Definition Represents the number of contingent annual payments under the asset acquisition agreement. No definition available.
|
| X | ||||||||||
- Definition Percentage of net sales revenue for contingent consideration from asset acquisition. No definition available.
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|